Mizuho analyst Vikram Malhotra raised the firm’s price target on Omega Healthcare (OHI) to $40 from $37 and keeps a Neutral rating on the shares. The firm believes the shares of senior housing real estate investment trusts are pricing in a lot of goof news.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $44 from $39 at Truist
- Omega Healthcare price target raised to $46 from $42 at Raymond James
- Omega Healthcare price target raised to $42 from $39 at Scotiabank
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results